article thumbnail

Eneboparatide Advances in Hypoparathyroidism Trial: Key Phase III Update

XTalks

Eneboparatide (AZP-3601), an investigational parathyroid hormone 1 receptor (PTH1R) agonist, met its primary endpoint in the CALYPSO Phase III trial, offering new data for adults with chronic hypoparathyroidism. AstraZeneca received eneboparatide during its $1.05 Without proper PTH function, patients may face kidney and bone complications.

Trials 59
article thumbnail

Adalvo signs licence deal with EQL Pharma for Mellozzan

Pharmaceutical Technology

“Adalvo brings to the table its regulatory expertise and then will put its extensive commercial engine to work with a view of laying out a globalisation roadmap for Mellozzan. Mellozzan contains the sleep hormone melatonin and is indicated for use in children with attention deficit hyperactivity disorder (ADHD) and sleep difficulties.

Hormones 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Learning on the fly

Scienmag

Computational model demonstrates similarity in how humans and insects learn about their surroundings Credit: University of Sussex Even the humble fruit fly craves a dose of the happy hormone, according to a new study from the University of Sussex which shows how they may use dopamine to learn in a similar manner to humans.

article thumbnail

Gut hormone triggers craving for more proteins

Scienmag

Revelations from a fly study could improve our understanding of protein malnutrition in humans. – Credit: Professor Greg Seong-Bae Suh, KAIST A new study led by KAIST researchers using fruit flies reveals how protein deficiency in the diet triggers cross talk between the gut and brain to induce a desire to eat foods rich in […].

Protein 52
article thumbnail

LegitScript Finds 1200 Percent Increase in Problematic Ads for Compounded GLP-1 Meds

XTalks

These advertisements, often found on social media platforms, search engines and various websites, frequently violate advertising guidelines and regulations. More than half a million individual ads referencing GLP-1s were monitored by LegitScript in just the last two months.

Pharmacy 104
article thumbnail

How AI could make therapeutic decision-making for breast cancer more accurate, affordable

Scienmag

Published in Nature Communications, ReceptorNet is a breakthrough deep-learning algorithm that can determine hormone-receptor status – a crucial biomarker for clinicians when deciding on the appropriate treatment path for breast cancer treatment Breast cancer affects 1/8 women in the USA, and rates of breast cancer are increasing.

article thumbnail

Could an Antibody Drug Help You Shed Pounds?

The Pharma Data

That’s one finding from an early study that tested the injection drug, which mimics the effects of a natural hormone called fibroblast growth factor 21 (FGF21). FGF21 is a hormone that helps control metabolism by stimulating certain receptors in fat tissue, the liver, the pancreas and the central nervous system. MONDAY, Nov.